Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
US dollar falls as Fed’s rate-hike cycle seen as likely done
Post Content Post Views: 132
Uber Technologies to issue $1.5 billion in convertible notes
Post Content Post Views: 143
Soccer-Violent clashes mar Brazil v Argentina World Cup qualifier
Post Content Post Views: 131
Natuzzi reports Q3 results
Post Content Post Views: 132
Nationwide S&P 500 Risk-Managed Income ETF declares monthly distribution of $0.1227
Post Content Post Views: 131
Wednesday’s economic calendar
Post Content Post Views: 136